STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study (STIGMA)
|ClinicalTrials.gov Identifier: NCT02796248|
Recruitment Status : Completed
First Posted : June 10, 2016
Last Update Posted : March 27, 2017
Stigma related to chronic disease is rejection or judgement or exclusion by others that is related to the chronic disease itself and is unwarranted. We are trying to figure out what proportion of young people with type 1 diabetes experience stigma in Canada. By young people, we mean teenagers and young adults; specifically, people who are between 14 and 25 years of age. This is a challenging period in life when identities are developed and peer opinions are felt to be particularly important. Experiencing stigma in this life period may be especially hurtful and may have bad effects on taking care of type 1 diabetes. This may lead to important medical problems like dangerously low or high blood sugar values. By understanding how common stigma is, we can figure out the need for programs and strategies to deal with it.
We will ask young people with type 1 diabetes to help us study this problem by completing an online survey. We will 'advertise' our study through type 1 diabetes clinics, websites, and social media. People who are eligible and interested will click on an internet link and be directed to the survey. Staff at clinics in Montreal, Calgary, and Vancouver will also draw their attention to the posters and/or provide small flyers with the internet link for the study.
Participants will be asked about their general sense of well-being, their habits and behaviours, and their blood sugar control, including frequency of both lows and highs. They will also be asked if they are willing to mail in a small blood sample. If yes, they will receive a kit with a small lancing device and instructions on how to clean their finger tip, prick it, and express a few drops of blood into a small container. They will then mail this back to us in a postage-paid envelope. We will use this to measure their hemoglobin A1c, an overall measure of blood sugar control.
We will use this information to (1) calculate the proportion of young people with type 1 diabetes who experience stigma; (2) figure out what factors and behaviours might predict or signal the experience of stigma; (3) see if there is a link between stigma and A1c control and/or frequent lows by report; (4) explore challenges and solutions voiced through the open-ended questions.
|Condition or disease||Intervention/treatment|
|Type 1 Diabetes Social Stigma||Other: cross-sectional survey|
|Study Type :||Observational|
|Actual Enrollment :||380 participants|
|Official Title:||STigma and Its Impact on Glucose Control aMong Youth With diAbetes, a Canada-Wide Study|
|Study Start Date :||May 2016|
|Actual Primary Completion Date :||January 2017|
|Actual Study Completion Date :||January 2017|
- Other: cross-sectional survey
This is an observation study. Participants will complete a survey at one occasion. Participants are also invited to do a A1c mail-in capillary test.
- Presence of stigma [ Time Frame: At survey completion ]Will be ascertained through a series of questions
- A1c [ Time Frame: At survey completion ]As noted, participants will be provided with a lancet and small container in which to express a couple of drops of blood. While this may cause some discomfort, given that all participants have type 1 diabetes, they are familiar with this procedure and express blood in this fashion regularly.
- Hypoglycemia frequency [ Time Frame: At survey completion; recall period varies from past week to past year ]Questions
- Diabetes-related self-efficicay [ Time Frame: At survey completion ]Questions based on Iannotti et al,. Developmental and Behavioral Pediatrics, 2006
- Diabetes-related distress [ Time Frame: At survey completion ]Questions based on Polonsky et al, Diabetes Care, 1995
- Quality of life [ Time Frame: At survey completion; recall period is past month ]Questions based on Varni et al. Diabetes Care 2003
- Well-Being Index [ Time Frame: At survey completion; recall period is past two months ]Questions from World Health Organization WHO (Five) Well-Being Index
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02796248
|Alberta Children's Hospital|
|Calgary, Alberta, Canada, T3B 6A8|
|Canada, British Columbia|
|British Columbia Children's Hospital|
|Vancouver, British Columbia, Canada, V6H 3V4|
|Centre Hospitalier Universitaire Sainte-Justine|
|Montreal, Quebec, Canada, H3T 1C5|
|McGill University Health Centre|
|Montreal, Quebec, Canada, H4A 3J1|
|Principal Investigator:||Kaberi Dasgupta, MD||McGill University Health Centre/Research Institute of the McGill University Health Centre|